Obesity is a global epidemic disease and a risk factor for heart metabolic complications, such as insulin sensitivity, type 2 diabetes, and non-alcoholic fatty liver disease [1]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.